Pournaras, Spyros Date of Birth: November 4, 1969 Place: Larissa 1
Total Page:16
File Type:pdf, Size:1020Kb
SPYROS POURNARAS, SHORT CURRICULUM VITAE, OCTOBER 2010 Name: Pournaras, Spyros Date of Birth: November 4, 1969 Place: Larissa 1993: Graduate, Medical School, Aristotle University of Thessaloniki (A.U.T.) 1995-1999: Registrar, Department of Microbiology, Medical School, A.U.T. 1999: Specialty of Medical Microbiology 2000: PhD, Medical School, A.U.T. 2001: Lecturer, Department of Microbiology, Medical School, University of Thessaly 2007: Assistant Professor, Department of Microbiology, Medical School, University of Thessaly 2009: Director, Department of Clinical Chemistry, Medical School, University of Thessaly PUBLICATIONS IN PEER-REVIEWED JOURNALS (SCI): 96 1st AUTHOR: 23 2nd AUTHOR: 18 3rd AUTHOR: 14 LAST AUTHOR: 11 OTHER POSITION: 30 CORRESPONDING AUTHOR: 18 SUM IMPACT FACTOR (IF): 379,350 MEAN IMPACT FACTOR (IF): 3,95 H-Index: 15 CITATIONS (ISI, SCOPUS 10/10/2010): 970 AUTHOR OF CHAPTERS IN INTERNATIONAL MEDICAL BOOKS: 2 Chapters MEMBER OF THE EDITORIAL BOARD OF PEER-REVIEWED JOURNALS: 1. Journal of Antimicrobial Chemotherapy (IF 4,352) 2 2. Chemotherapy Research and Practice REVIEWER OF PEER-REVIEWED JOURNALS: i) Journal of Antimicrobial Chemotherapy ii) Journal of Medical Microbiology iii) BMC Microbiology iv) BMC Infectious Diseases v) Indian Journal of Cancer vi) Joural of Medical Virology vii) Clinical Microbiology and Infection viii) Photomedicine and Laser Surgery ix) Recent Patents On Anti-Infective Drug Discovery x) Clinical Chemistry xi) Expert Opinion in Investigating Drugs xii) Scandinavian Journal of Infectious Diseases xiii) Current Drug Targets xiv) Applied and Environmental Microbiology xv) Antimicrobial Agents and Chemotherapy xvi) Journal of Clinical Microbiology xvii) Journal of Infection xviii) Microbiology 3 Impact Factors, IF (2009) Journal IF Publications No Sum IF J Antimicrob Chemother 4,352 25 108,800 J Clin Microbiol 4,162 15 62,430 Antimicrob Agents Chemother 4,802 8 38,416 Eur J Clin Microbiol Infect Dis 2,605 3 7,815 Diagn Microbiol Infect Dis 2,451 1 2,451 J Clin Virol 3,124 1 3,124 Gynecol Oncol 3,733 1 3,733 J Clin Lab Anal 0,855 1 0,855 Occup Med 1,124 1 1,124 Lett Appl Microbiol 1,640 2 3,280 Fertil Steril 3,970 4 15,880 Hum Reprod 3,859 1 3,859 Comp Immunol 2,986 2 5,972 Microbiol Infect Dis J Infect 3,060 1 3,060 Chemotherapy 2,028 1 2,028 Inf Control Hosp Epidemiol 2,768 2 5,536 Int J Antimicrob Agents 3,032 3 9,096 Journal of Medical Microbiology 2,272 1 2,272 Clin Microbiol Infect 4,014 5 20,070 Epidemiol Infect 2,362 2 4,724 Emerg Infect Dis 6,794 2 13,588 Lancet 30,758 1 30,758 Microb Drug Resist 1,989 2 3,978 Scand J Infect Dis 1,700 1 1,700 Biochemistry 3,226 1 3,226 FEMS Microbiol Lett 2,199 1 2,199 Infection 2,051 1 2,051 Food Microbiology 3,216 1 3,216 Seminars in Hematology 2,703 1 2,703 Eur J Clin Invest 2,643 1 2,643 Microb Pathog 2,324 1 2,324 J Hosp Infect 3,012 1 3,012 J Endocrinol Invest 1,347 1 1,347 Reprod Biol Endocrinol 2,08 1 2,08 96 379,350 Total 4 List of publications in peer-reviewed journals 1. Tsakris A, Pournaras S, Douboyas J. “Changes in antimicrobial resistance of enterococci isolated in Greece”. J Antimicrob Chemother 1997; 40:735-737. 2. Tsakris A, Woodford N, Pournaras S, Kaufmann M, Douboyas J. “Apparent increased prevalence of high-level aminoglycoside-resistant Enterococcus durans resulting from false identification by a semiautomated software system”. J Clin Microbiol 1998; 36:1419-1421. 3. Skoura L, Efstratiou A, Tsakris A, Pournaras S, George RC, Douboyas J. “Study on the use of an enzyme-linked immunosorbent assay in determining human antibodies to diphtheria toxin as compared with a reference toxin neutralization assay”. Comp Immunol Microbiol Infect Dis 1999; 22:181-186. 4. Tsakris A, Pournaras S, Hathi D, Douboyas J, Efstratiou A. “Outbreak of rare serotype of group A streptococcus pharyngitis in a boarding college”. Lancet 1999; 353:1585-1586. 5. Pournaras S, Tsakris A, Mandraveli K, Faitatzidou A, Douboyas J, Tourkantonis A. “Reported needlestick and sharp injuries among health care workers in a Greek general hospital”. Occup Med 1999; 49:423-426. 6. Pournaras S, Tsakris A, Hadjichristodoulou C, Skoura L, Souliou E, Antoniadis A, Douboyas J. “Diphtheria immunity of Albanian and other eastern European immigrants in Greece compared with the local population. The risk of reemergence in Greece”. Infection 1999; 27:361-364. 7. Tsakris A, Pournaras S, Woodford N, Palepou MFI, Babini GS, Douboyas J, Livermore DM. “Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece”. J Clin Microbiol 2000; 38:1290-1292. 8. Polyzou A, Sofianou D, Pournaras S, Tsakris A. “RAPD-fingerprinting of Serratia marcescens after formaldeyde inactivation of DNAse activity”. Lett Appl Microbiol 2000; 30:419-421. 9. Tsakris A, Pantazi A, Pournaras S, Maniatis A, Polyzou A, Sofianou D. “Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system”. J Clin Microbiol 2000; 38:3505-3507. 10. Pournaras S, Efstratiou A, Douboyas J, George RC, Tsakris A. “Genetic relatedness of group A streptococci of the newly designated serotype M90 causing a food-borne outbreak and sporadic infections”. Epidemiol Infect 2000; 125:299-301. 5 11. Pournaras S, Tsakris A, Kaufmann ME, Douboyas J, Antoniadis A. “Outbreak of infections in a Greek university hospital involving a single clone of high-level aminoglycoside-resistant Enterococcus faecalis”. Inf Control Hosp Epidemiol 2000; 21:786-789. 12. Pournaras S, Tsakris A, Palepou MFI, Papa A, Douboyas J, Antoniadis A, Woodford N. “Pheromone responses and high-level aminoglycoside resistance of conjugative plasmids of Enterococcus faecalis from Greece”. J Antimicrob Chemother 2000; 46:1013-1016. 13. Mavroidi A, Tsakris A, Tzelepi E, Pournaras S, Loukova V, Tzouvelekis LS. “Carbapenem- hydrolysing VIM-2 metallo--lactamase in Pseudomonas aeruginosa from Greece”. J Antimicrob Chemother 2000; 46:1041-1043. 14. Pournaras S, Slavakis A, Polyzou A, Sofianou D, Maniatis AN, Tsakris A. “Nosocomial spread of an unusual methicillin-resistant Staphylococcus aureus clone that is sensitive to all non--lactam antibiotics, including tobramycin”. J Clin Microbiol 2001; 39:779-781. 15. Tsakris A, Pournaras S, Maniatis AN, Douboyas J, Antoniadis A. “Increasing prevalence of high-level gentamicin-resistance among enterococci isolated in Greece”. Chemotherapy 2001; 47:86-89. 16. Petinaki E, Miriagou V, Tzouvelekis LS, Pournaras S, Hatzi F, Kontos F, Maniati M, Maniatis AN and the Bacterial resistance Study Group of Thessaly. “Methicillin-resistant Staphylococcus aureus in the hospitals of central Greece”. IntJ Antimicrob Agents 2001; 18:61-65. 17. Polyzou A, Slavakis A, Pournaras S, Maniatis AN, Sofianou D, Tsakris A. “Predominance of a susceptible to erythromycin and several other non--lactam antibiotics methicillin-resistant Staphylococcus aureus clone in a Greek hospital”. J Antimicrob Chemother 2001; 48:231-234. 18. Maniatis AN, Pournaras S, Kanellopoulou M, Kontos F, Dimitroulia E, Papafrangas E, Tsakris A. “Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary greek hospital”. J Clin Microbiol 2001; 39:4571-4574. 19. Kartali G, Tzelepi E, Pournaras S, Kontopoulou C, Kontos F, Sofianou D, Maniatis AN, Tsakris A. “Outbreak of infections caused by Enterobacter cloacae producing the integron-associated β- lactamase IBC-1 in a neonatal intensive care unit of a greek hospital”. Antimicrob Agents Chemother 2002; 46:1577-1580. 20. Tsakris A, Hassapopoulou H, Skoura L, Pournaras S, Douboyas J. “ Leg ulcer due to Pseudomonas luteola in a patient with sickle cell disease.” Diagn Microbiol Infect Dis 2002; 42:141- 143. 6 21. Pournaras S, Tsakris A, Maniati M, Tzouvelekis LS, Maniatis AN. “Novel variant (blaVIM-4) of the metallo-β-lactamase gene blaVIM-1 in a clinical strain of Pseudomonas aeruginosa”. Antimicrob Agents Chemother 2002; 46:4026- 4028. 22. Pournaras S, Maniati M, Petinaki E, Tzouvelekis LS, Tsakris A, Legakis NJ, Maniatis AN. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo- {beta}-lactamase gene variants blaVIM-2 and blaVIM-4. J Antimicrob Chemother 2003; 51:1409-1414. 23. Maniatis AN, Pournaras S, Orkopoulou S, Tassios PT, Legakis NJ, and the Bacterial Resistance Study Group. Multi-resistant Acinetobacter baumannii isolates in intensive care units in Greece. Clin Microbiol Infect 2003; 9:547-553. 24. Tsakris A, Tsioni C, Pournaras S, Polyzos S, Maniatis AN, Sofianou D. Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital. J Antimicrob Chemother 2003; 52:1046-1047. 25. Pournaras S, Malamou-Lada H, Maniati M, Mylona-Petropoulou D, Vagiakou-Voudris H, Tsakris A, Maniatis AN. Persistence of a clone of glycopeptide-resistant Enterococcus faecalis among patients in an intensive care unit of a Greek hospital. J Antimicrob Chemother 2004; 53:109-112. 26. Sofianou D, Avgoustinakis E, Dilopoulou A, Pournaras S, Tsirakidis G, Tsakris A. Soft-tissue abscess involving Actinomyces odontolyticus and two Prevotella species in an intravenous drug abuser. Comp Immunol Microbiol Infect Dis 2004; 27:75-79. 27. Kanellopoulou M, Pournaras S, Iglezos H, Papafrangas E, Maniatis AN. Persistent Colonization of Nine Cystic Fibrosis Patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis 2004; 23:336-339. 28. Pournaras S, Ikonomidis A, Sofianou D, Tsakris A, Maniatis AN. CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece. Emerg Infect Dis 2004; 10: 1163-1164. 29. Polyzou A, Pournaras S, Dafni U, Sofianou D, Christeli E, Patrinos S, Tsakris A. Seroepidemiology of Bordetella pertussis immune responses in a healthy population in Northern Greece. J Clin Lab Anal 2004; 18: 211-214.